![Cerbios-Pharma SA](/logoCERBIOS-comp307411.jpg)
Cerbios-Pharma SA
About
Company description
With over 40 years in the pharmaceutical industry,
Cerbios Pharma is a privately held company with headquarter in
Lugano, Switzerland, specializing in the development and manufacture
of :
- Probiotic based finished formulations (targeting different therapeutic
areas), based on its own proprietary probiotic strain SF68
- Chemical and biological APIs: (Methyl-folate; 5 MTHF: biologically
active form of folic acid)
Microbiota
(gut bacteria) impacts on health of several body districts, gut, skin,
metabolism, immune system, CNS. Probiotics can balance microbiota with positive
effects on some pathologies.
Cerbios
developed finished formulations targeting different syndromes, supporting
efficacy with scientific evidences and trials.
FINISHED
FORMULATIONS BASED ON PROBIOTICS:
- SF68 SKINActive: management and prevention of acne and seborrheic dermatitis. Clinically Proven
- SF68 IMMUNO: boosting immune system. Scientifically backed.
- SF68 SLIPIDÒ: to manage and prevent dyslipidemias, obesity and metabolic syndrome. Clinically Proven
- SF68 IBSoft: for management and prevention of IBS symptoms. Clinically Proven
- NEWFLORA: for treatment of diarrhea, traveler’s diarrhea, infective diarrhea. Drug product: with e-CTD and CPP from Switzerland
- (Methyl-folate/ 5 MTHF): biologically active form of folic acid.
Quick facts
Sales markets | Asia; Central/South America; Eastern Europe; Middle East; Western Europe |
---|---|
Primary business activity | Manufacturer: Finished Food Products |
Affiliated categories: | Food Supplements / Nutraceuticals |Pharmaceutical Ingredients |Postbiotics More |